HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas Podsadecki Selected Research
Thomas Podsadecki Research Topics
Disease
14
Infections
07/2017 - 01/2013
8
Fibrosis (Cirrhosis)
07/2017 - 01/2014
5
Chronic Hepatitis C
12/2017 - 07/2013
4
Hepatitis C
04/2016 - 01/2013
4
Body Weight (Weight, Body)
05/2014 - 01/2014
2
Coinfection
04/2016 - 03/2015
1
Virus Diseases (Viral Diseases)
12/2017
1
Anemia
06/2016
1
Chronic Kidney Failure (Chronic Renal Failure)
06/2016
1
Chronic Renal Insufficiency
06/2016
1
HIV Infections (HIV Infection)
04/2016
1
Drug-Related Side Effects and Adverse Reactions
01/2016
Drug/Important Bio-Agent (IBA)
13
Ribavirin (Virazole)
FDA Link
Generic
07/2017 - 01/2013
12
paritaprevir
IBA
07/2017 - 01/2013
12
dasabuvir
IBA
07/2017 - 01/2013
12
Ritonavir (Norvir)
FDA Link
07/2017 - 01/2013
11
Interferons
IBA
01/2016 - 01/2013
10
Antiviral Agents (Antivirals)
IBA
12/2017 - 01/2013
10
ombitasvir
IBA
07/2017 - 01/2014
5
Protease Inhibitors (Protease Inhibitor)
IBA
08/2014 - 01/2013
3
telaprevir
IBA
01/2016 - 04/2014
1
glecaprevir and pibrentasvir
IBA
12/2017
1
Erythropoietin
FDA Link
06/2016
1
Human immunodeficiency virus 1 p16 protease
IBA
04/2016
1
Rilpivirine (TMC-278)
IBA
01/2016
1
Raltegravir Potassium
FDA Link
03/2015
1
Atazanavir Sulfate (Reyataz)
FDA Link
03/2015
1
RNA (Ribonucleic Acid)
IBA
03/2015
1
dimemorfan (AT 17)
IBA
03/2015
1
Nucleosides
IBA
08/2014
1
Tablets
IBA
04/2014
1
Placebos
IBA
04/2014
Therapy/Procedure
8
Therapeutics
12/2017 - 01/2013
1
Renal Dialysis (Hemodialysis)
06/2016
1
Aftercare (After-Treatment)
02/2015
1
Retreatment
04/2014